Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Work In Process (2016 - 2024)

Historic Work In Process for Fresenius Medical Care AG (FMS) over the last 16 years, with Q4 2024 value amounting to $132.6 million.

  • Fresenius Medical Care AG's Work In Process fell 757.25% to $132.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $132.6 million, marking a year-over-year decrease of 757.25%. This contributed to the annual value of $132.6 million for FY2024, which is 757.25% down from last year.
  • As of Q4 2024, Fresenius Medical Care AG's Work In Process stood at $132.6 million, which was down 757.25% from $143.5 million recorded in Q4 2023.
  • In the past 5 years, Fresenius Medical Care AG's Work In Process ranged from a high of $143.5 million in Q4 2023 and a low of $120.4 million during Q4 2021
  • Its 5-year average for Work In Process is $128.9 million, with a median of $126.9 million in 2022.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Work In Process soared by 1422.7% in 2020, and later plummeted by 757.25% in 2024.
  • Fresenius Medical Care AG's Work In Process (Quarter) stood at $120.9 million in 2020, then decreased by 0.41% to $120.4 million in 2021, then grew by 5.4% to $126.9 million in 2022, then rose by 13.04% to $143.5 million in 2023, then decreased by 7.57% to $132.6 million in 2024.
  • Its Work In Process was $132.6 million in Q4 2024, compared to $143.5 million in Q4 2023 and $126.9 million in Q4 2022.